![[HTML version]](/e/graphics/htmlborder.gif)
![[PDF version]](/e/graphics/pdfborder.gif)
![[CIF]](/e/graphics/cifborder.gif)
![[3d view]](/e/graphics/3dviewborder.gif)
![[Structure Factors]](/e/graphics/structurefactorsborder.gif)
![[Supplementary Material]](/e/graphics/supplementarymaterialsborder.gif)
![[CIF check Report]](/e/graphics/checkcifborder.gif)
![[Open access]](/e/graphics/free.gif)
![[Contents scheme]](kp2155contents.gif)
Acta Cryst. (2008). E64, o547 [ doi:10.1107/S1600536808003073 ]
Abstract: In the title compound, C11H9BrN2O, the molecules are linked into R22(8) dimers by paired N-H
O hydrogen bonds and these dimers are further stacked into columns along the c axis by
-
interactions between pyrazinone rings [centroid-centroid distance = 3.544 Å; the dihedral angle between the planes of these rings is 7.51 (16)°]. The title compound is a precursor for agents with potential use as pharmaceuticals.
Online 6 February 2008
Copyright © International Union of Crystallography
IUCr Webmaster